Predictive and systems modeling of exosome cargo
外泌体货物的预测和系统建模
基本信息
- 批准号:10321649
- 负责人:
- 金额:$ 73.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAffectAgeAllogenicAutologousBiocompatible MaterialsBiological AssayBiological MarkersBiological ModelsBiopsyBloodCD34 geneCardiacCardiac MyocytesCardiovascular DiseasesCardiovascular systemCell TherapyCell TransplantationCellsChildChild health careChildhoodClinical TrialsCollaborationsComputational BiologyComputer AnalysisCongestive Heart FailureDataDiagnosticDiseaseEndothelial CellsEpigenetic ProcessExposure toExtracellular SpaceFibroblastsFibrosisGenderGene ExpressionGene Expression RegulationGenetic TranscriptionGrowth FactorHeart failureHumanHypoxiaImageIn VitroIndividualInfarctionInjectionsIschemiaLabelLeast-Squares AnalysisLipoproteinsMatched GroupMeasuresMechanicsMediatingMethodsMicroRNAsModelingMorbidity - disease rateMultivariate AnalysisMuscle CellsMyocardial InfarctionMyocardiumNatural regenerationNewborn InfantOperative Surgical ProceduresOutcomePathway interactionsPatientsPeptide Sequence DeterminationProteinsPublishingRNARattusRegenerative capacityRegression AnalysisReperfusion InjuryReperfusion TherapyRoleSamplingSignal TransductionSourceSpeedSurgeonSystemSystems BiologyTherapeuticTherapy trialTissuesage effectage groupage relatedangiogenesisbasecardiac repaircardioprotectioncell typeearly childhoodeffective therapyexosomefunctional improvementgene therapyhealingheart functionhemodynamicshorizontal cellimmunogenicityimprintimprovedimproved functioningin vivomicrovesiclesmortalitynormoxiaparacrinepreventregeneration potentialregenerativeregenerative cellrepairedresponsesexstemstem cell functionstem cellstherapeutic miRNAuptake
项目摘要
Abstract
Adverse remodeling of the myocardium after myocardial infarction speeds progression to
heart failure. While cell therapy has been met with great enthusiasm, there are numerous
shortcomings that prevent long-term functional improvements. Moreover, these cells come from
diseased individuals and immunogenicity limits most studies to autologous therapy. Finally, it is
widely believed that the main effect of cell therapy is mediated by paracrine effectors and not
the cells themselves.
Our published studies demonstrate that rat cardiac progenitor cells (CPCs) make
exosomes, and when cells are exposed to hypoxia, exosomes are reparative following
infarction. Moreover, we were able to demonstrate potential pathways using computational and
systems biology. Recently, we have been able to isolate CPCs from pediatric biopsies and
show age-related changes in cell therapy in a model of heart failure. Preliminary studies
demonstrate that these exosomes also vary in function by age and hypoxia. Therefore, the
objective of this proposal is to examine the protective/regenerative capacity of human pediatric
CPC exosomes in rat models of ischemia-reperfusion. Additionally, with a large number of
patient samples from a wide variety of children, we can perform multivariate analysis to examine
the factors that affect various in vivo mechanisms. Factors include patient age, gender, and
exposure to hypoxic conditions. Finally, we will expand our model by looking at reparative
exosomes from other cell types, CD34+ cells, and examine whether mechanisms of hypoxic
exosome function are conserved among different cells.
Completion of the proposed studies will determine whether hypoxic exosomes are a
beneficial therapy for ischemia-reperfusion injury, as well as determine potential patient factors
that contribute to these responses.
抽象的
心肌梗塞后心肌的不良重塑加速了心肌梗塞的进展
心脏衰竭。尽管细胞疗法受到了极大的热情,但仍有许多
阻碍长期功能改进的缺点。而且,这些细胞来自
患病个体和免疫原性将大多数研究限制为自体治疗。最后,就是
人们普遍认为细胞疗法的主要作用是由旁分泌效应器介导的,而不是
细胞本身。
我们发表的研究表明,大鼠心脏祖细胞 (CPC) 使
外泌体,当细胞暴露于缺氧时,外泌体会进行修复
梗塞。此外,我们能够使用计算和方法来证明潜在的途径
系统生物学。最近,我们已经能够从儿科活检中分离出 CPC,
显示心力衰竭模型中细胞疗法与年龄相关的变化。初步研究
证明这些外泌体的功能也会因年龄和缺氧而变化。因此,
该提案的目的是检查人类儿科的保护/再生能力
大鼠缺血再灌注模型中的 CPC 外泌体。此外,随着大量
来自各种儿童的患者样本,我们可以进行多变量分析来检查
影响各种体内机制的因素。因素包括患者年龄、性别
暴露于缺氧条件。最后,我们将通过研究修复来扩展我们的模型
来自其他细胞类型、CD34+细胞的外泌体,并检查缺氧机制是否
外泌体的功能在不同细胞之间是保守的。
拟议研究的完成将确定缺氧外泌体是否是一种
对缺血再灌注损伤的有益治疗,以及确定潜在的患者因素
有助于这些反应。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Intramyocardial cell-based therapy with Lomecel-B during bidirectional cavopulmonary anastomosis for hypoplastic left heart syndrome: the ELPIS phase I trial.
在左心发育不全综合征双向腔肺吻合术中使用 Lomecel-B 进行心肌内细胞治疗:ELPIS I 期试验。
- DOI:
- 发表时间:2023-03
- 期刊:
- 影响因子:0
- 作者:Kaushal, Sunjay;Hare, Joshua M;Hoffman, Jessica R;Boyd, Riley M;Ramdas, Kevin N;Pietris, Nicholas;Kutty, Shelby;Tweddell, James S;Husain, S Adil;Menon, Shaji C;Lambert, Linda M;Danford, David A;Kligerman, Seth J;Hibino, Narutoshi;Korutla, La
- 通讯作者:Korutla, La
The Effect of Parent Cell Type on Small Extracellular Vesicle-Derived Vehicle Functionality.
亲代细胞类型对小细胞外囊泡衍生载体功能的影响。
- DOI:10.1002/adbi.202300462
- 发表时间:2023-12-24
- 期刊:
- 影响因子:3.7
- 作者:Sruti Bheri;Hyun;J. Hoffman;Felipe Takaesu;Michael E. Davis
- 通讯作者:Michael E. Davis
Using Statistical Modeling to Understand and Predict Pediatric Stem Cell Function.
使用统计模型来理解和预测儿科干细胞功能。
- DOI:10.1161/circgen.118.002403
- 发表时间:2019-05-17
- 期刊:
- 影响因子:0
- 作者:Farnaz Shoja;A. George;Udit Agarwal;M. Platt;G. Gibson;Michael E. Davis
- 通讯作者:Michael E. Davis
Knockdown of deleterious miRNA in progenitor cell-derived small extracellular vesicles enhances tissue repair in myocardial infarction.
祖细胞来源的小细胞外囊泡中有害 miRNA 的敲低可增强心肌梗塞的组织修复。
- DOI:
- 发表时间:2023-03-03
- 期刊:
- 影响因子:13.6
- 作者:Park, Hyun;Hoffman, Jessica R;Brown, Milton E;Bheri, Sruti;Brazhkina, Olga;Son, Young Hoon;Davis, Michael E
- 通讯作者:Davis, Michael E
Customized Loading of microRNA-126 to Small Extracellular Vesicle-Derived Vehicles Improves Cardiac Function after Myocardial Infarction.
将 microRNA-126 定制加载到小型细胞外囊泡衍生载体中可改善心肌梗死后的心脏功能。
- DOI:
- 发表时间:2023-10-24
- 期刊:
- 影响因子:17.1
- 作者:Bheri, Sruti;Brown, Milton E;Park, Hyun;Brazhkina, Olga;Takaesu, Felipe;Davis, Michael E
- 通讯作者:Davis, Michael E
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael E Davis其他文献
Differential Regulation of Vascular Smooth Muscle Nuclear Factor Kappa-b by Gq-coupled and Cytokine Receptors
Gq 偶联受体和细胞因子受体对血管平滑肌核因子 Kappa-b 的差异调节
- DOI:
10.1042/bj3440889 - 发表时间:
1999 - 期刊:
- 影响因子:0
- 作者:
Karen L Abbott;A. Robida;Michael E Davis;G. Pavlath;Jean M. Camden;John T. Turner;T. Murphy;K. L. A;A. M. R;M. E. D;G. K. P;J. M. C;J. T. T;T. J. M. Differential - 通讯作者:
T. J. M. Differential
Michael E Davis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael E Davis', 18)}}的其他基金
相似国自然基金
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
运动状态下代谢率的年龄变化特征及对人体热舒适的影响研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
基于堆叠式集成学习探索人居环境对生物学年龄的影响
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 73.68万 - 项目类别:
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:
10748606 - 财政年份:2024
- 资助金额:
$ 73.68万 - 项目类别:
Early Life Stress Induced Reprogramming of Vascular Function by the Endothelium and Macrophage Systems
生命早期的压力诱导内皮细胞和巨噬细胞系统对血管功能进行重新编程
- 批准号:
10555125 - 财政年份:2023
- 资助金额:
$ 73.68万 - 项目类别:
Identifying and testing a tailored strategy to achieve equity in blood pressure control in PACT
确定并测试量身定制的策略,以在 PACT 中实现血压控制的公平性
- 批准号:
10538513 - 财政年份:2023
- 资助金额:
$ 73.68万 - 项目类别: